Four years into MACRA: What has changed?
Autor: | Jackson Kim, Scott D. Bieber, Jonathan Cheng, Eugene Lin |
---|---|
Rok vydání: | 2020 |
Předmět: |
media_common.quotation_subject
030232 urology & nephrology 030204 cardiovascular system & hematology Patient advocacy Article Reimbursement Mechanisms 03 medical and health sciences 0302 clinical medicine Nursing Multidisciplinary approach medicine Humans Quality (business) Medicare Access and CHIP Reauthorization Act of 2015 Value-Based Health Insurance health care economics and organizations Reimbursement Health policy Kidney transplantation media_common business.industry Health Policy medicine.disease Payment United States Nephrology Kidney Diseases business Kidney disease |
Zdroj: | Semin Dial |
ISSN: | 1525-139X 0894-0959 |
Popis: | In 2015, Congress passed the Medicare Access and CHIP Reauthorization Act (MACRA), a policy intended to transition Medicare away from pure fee-for-service care to value-based care. MACRA does this by evaluating the cost and quality of providers, resulting in financial bonuses and penalties in Medicare reimbursement. MACRA offers two tracks for participation, the Merit-based Incentive Payment System and the Advanced Alternative Payment Models. Although the payment rules are different for each of the tracks, common to both is an emphasis on holding providers accountable for high-quality, cost-efficient care. Early data suggest that the End-stage renal disease Seamless Care Organizations, an Advanced Alternative Payment Model, resulted in cost-savings concurrent with improved care quality. Additionally, on July 10(th) 2019, the President signed an executive order that further attempts to improve kidney disease care by shifting its focus away from in-center hemodialysis and towards chronic kidney disease care, home-based dialysis, kidney transplantation, and innovating new therapies for kidney disease. These changes to nephrology reimbursement present a unique opportunity to improve patient outcomes in a cost-effective way. A multidisciplinary effort among policy makers, nephrology providers, and patient advocacy groups is critical to ensure these changes in care delivery safeguard and improve patient health. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |